Search by Drug Name or NDC

    NDC 50090-5949-00 Ozempic 1.34 mg/mL Details

    Ozempic 1.34 mg/mL

    Ozempic is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by A-S Medication Solutions. The primary component is SEMAGLUTIDE.

    Product Information

    NDC 50090-5949
    Product ID 50090-5949_a5c23c93-1c61-4768-b7f2-1e430cd21a8d
    Associated GPIs
    GCN Sequence Number 081168
    GCN Sequence Number Description semaglutide PEN INJCTR 1/0.75 (3) SUBCUT
    HIC3 C4I
    HIC3 Description ANTIHYPERGLY,INCRETIN MIMETIC(GLP-1 RECEP.AGONIST)
    GCN 48208
    HICL Sequence Number 044675
    HICL Sequence Number Description SEMAGLUTIDE
    Brand/Generic Generic
    Proprietary Name Ozempic
    Proprietary Name Suffix n/a
    Non-Proprietary Name semaglutide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 1.34
    Active Ingredient Units mg/mL
    Substance Name SEMAGLUTIDE
    Labeler Name A-S Medication Solutions
    Pharmaceutical Class GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA209637
    Listing Certified Through 2024-12-31

    Package

    NDC 50090-5949-00 (50090594900)

    NDC Package Code 50090-5949-0
    Billing NDC 50090594900
    Package 1 SYRINGE, PLASTIC in 1 CARTON (50090-5949-0) / 3 mL in 1 SYRINGE, PLASTIC
    Marketing Start Date 2022-04-01
    NDC Exclude Flag N
    Pricing Information N/A